Lowering Affymax's Fair Value - Toronto Star PDF Print
Toronto StarHematide did prove noninferiority and comparable safety to Amgen's Epogen in patients undergoing dialysis, and we think this could form the basis for

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.